BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Chun-Yi Lin, Jin-Hua Chen, Ji-An Liang, Cheng-Chieh Lin, Long-Bin Jeng, Chia-Hung Kao. 18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: A systematic review and meta-analysisEuropean Journal of Radiology 2012; 81(9): 2417 doi: 10.1016/j.ejrad.2011.08.004
2
Nobuyuki Hayakawa, Yuji Nakamoto, Koya Nakatani, Etsuro Hatano, Satoru Seo, Tatsuya Higashi, Tsuneo Saga, Shinji Uemoto, Kaori Togashi. Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patientsInternational Journal of Clinical Oncology 2014; 19(6): 1020 doi: 10.1007/s10147-013-0653-3
3
Abdelhamid H. Elgazzar. Synopsis of Pathophysiology in Nuclear Medicine2014; : 191 doi: 10.1007/978-3-319-03458-4_9
4
E. Edmund Kim, Hyung-Jun Im, Dong Soo Lee, Keon Wook Kang. Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT2016; : 199 doi: 10.1007/978-3-319-28652-5_2
5
Tamer Özülker, Filiz Özülker. Atlas of PET-CT Imaging in Oncology2015; : 311 doi: 10.1007/978-3-319-18994-9_10
6
Ekhlas Abdelmonem Ibrahem Nasr Shaban. Can fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography detect hepatocellular carcinoma and its extrahepatic metastases?The Egyptian Journal of Radiology and Nuclear Medicine 2018; 49(1): 196 doi: 10.1016/j.ejrnm.2017.10.014
7
Xiaoli Liao, Junbao Wei, Yongqiang Li, Jianhong Zhong, Zhihui Liu, Sina Liao, Qian Li, Changyuan Wei. 18F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinomaMedicine 2018; 97(34): e11970 doi: 10.1097/MD.0000000000011970
8
Sung Hoon Kim, Kyoung Sook Won, Byung Wook Choi, Il Jo, Seok Kil Zeon, Woo Jin Chung, Jung Hyeok Kwon. Usefulness of F-18 FDG PET/CT in the Evaluation of Early Treatment Response After Interventional Therapy for Hepatocellular CarcinomaNuclear Medicine and Molecular Imaging 2012; 46(2): 102 doi: 10.1007/s13139-012-0138-8
9
Anna Maria De Gaetano, Vittoria Rufini, Paola Castaldi, Anna Maria Gatto, Laura Filograna, Alessandro Giordano, Lorenzo Bonomo. Clinical applications of 18F-FDG PET in the management of hepatobiliary and pancreatic tumorsAbdominal Imaging 2012; 37(6): 983 doi: 10.1007/s00261-012-9845-y
10
Jean-Noël Talbot, Laure Michaud, Jean-Didier Grange, Olivier Rosmorduc, Sona Balogova. Use of choline PET for studying hepatocellular carcinomaClinical and Translational Imaging 2014; 2(2): 103 doi: 10.1007/s40336-014-0055-1
11
Hyo Jung Seo, Yun Jung Choi, Hyun Jeong Kim, Yong Hyu Jeong, Arthur Cho, Jae Hoon Lee, Mijin Yun, Hye Jin Choi, Jong Doo Lee, Won Jun Kang. Evaluation of Bone Metastasis from Hepatocellular Carcinoma Using 18F-FDG PET/CT and 99mTc-HDP Bone Scintigraphy: Characteristics of Soft Tissue FormationNuclear Medicine and Molecular Imaging 2011; 45(3): 203 doi: 10.1007/s13139-011-0099-3
12
Swati Rachh, Sandip Basu. PET/CT in patients with liver lesions of different natureClinical and Translational Imaging 2014; 2(2): 139 doi: 10.1007/s40336-014-0061-3
13
Benedikt M. Schaarschmidt, Lino M. Sawicki, Gerald Antoch, Philipp Heusch. PET/MR Imaging: Current and Emerging Applications2018; : 23 doi: 10.1007/978-3-319-69641-6_3
14
Ilaria Grassi, Joshua James Morigi, Cristina Nanni, Stefano Fanti. FDG and other radiopharmaceuticals in the evaluation of liver lesionsClinical and Translational Imaging 2014; 2(2): 115 doi: 10.1007/s40336-014-0059-x